| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Nitya Nair | Q57865288 |
| Garry P. Nolan | Q89180933 | ||
| Holden T. Maecker | Q93173386 | ||
| P2093 | author name string | Shih-Yu Chen | |
| Mark Genovese | |||
| C Garrison Fathman | |||
| Chan C Whiting | |||
| Henrik E Mei | |||
| Matthew Hale | |||
| P2860 | cites work | Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum | Q24594356 |
| The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens | Q24646963 | ||
| A deep profiler's guide to cytometry | Q26824238 | ||
| Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE | Q27003201 | ||
| A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate | Q28295474 | ||
| Cytokines in the pathogenesis of rheumatoid arthritis | Q28303865 | ||
| Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group | Q29616063 | ||
| High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis | Q30419111 | ||
| Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes | Q30543634 | ||
| Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. | Q30550855 | ||
| Critical assessment of automated flow cytometry data analysis techniques. | Q30587564 | ||
| viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia | Q30628090 | ||
| Cytobank: providing an analytics platform for community cytometry data analysis and collaboration | Q30769385 | ||
| Cartilage degradation by stimulated human neutrophils: reactive oxygen species decrease markedly the activity of proteolytic enzymes | Q30950426 | ||
| MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients | Q33692506 | ||
| Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. | Q33766404 | ||
| Automated identification of stratifying signatures in cellular subpopulations | Q33854094 | ||
| Leveraging human genetics to develop future therapeutic strategies in rheumatoid arthritis | Q33888733 | ||
| Multiplexed ion beam imaging of human breast tumors | Q33949706 | ||
| A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis | Q33982255 | ||
| Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE | Q34037159 | ||
| From single cells to deep phenotypes in cancer | Q34287095 | ||
| Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators | Q34294698 | ||
| The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner | Q34307377 | ||
| CytoSPADE: high-performance analysis and visualization of high-dimensional cytometry data | Q34332830 | ||
| Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial | Q34530459 | ||
| Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry | Q34992218 | ||
| Evidence supporting the benefit of early intervention in rheumatoid arthritis | Q34999223 | ||
| Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. | Q51978495 | ||
| Cytokine production by synovial T cells in rheumatoid arthritis | Q77745456 | ||
| Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus | Q81000909 | ||
| Expansion of a unique macrophage subset in rheumatoid arthritis synovial lining layer | Q81828653 | ||
| CD11c as a transcriptional biomarker to predict response to anti-TNF monotherapy with adalimumab in patients with rheumatoid arthritis | Q82332974 | ||
| Tissue factor expression in rheumatoid synovium: a potential role in pannus invasion of rheumatoid arthritis | Q86382359 | ||
| Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry | Q35105312 | ||
| The microbiome and rheumatoid arthritis | Q35743863 | ||
| Emerging biologic therapies in rheumatoid arthritis: cell targets and cytokines. | Q36101614 | ||
| The role of RANK ligand/osteoprotegerin in rheumatoid arthritis | Q36111285 | ||
| Synovial fibroblasts: key players in rheumatoid arthritis | Q36433286 | ||
| Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways | Q36568516 | ||
| Macrophages in rheumatoid arthritis | Q36748422 | ||
| Mechanistic biomarkers for clinical decision making in rheumatic diseases | Q36905584 | ||
| The central role of T cells in rheumatoid arthritis | Q36988984 | ||
| Cells of the synovium in rheumatoid arthritis. Chondrocytes | Q37000837 | ||
| Redox signalling and the inflammatory response in rheumatoid arthritis. | Q37142186 | ||
| A platinum-based covalent viability reagent for single-cell mass cytometry. | Q37257000 | ||
| The immunopathogenesis of rheumatoid arthritis | Q37309424 | ||
| Single-cell mass cytometry for analysis of immune system functional states | Q37330089 | ||
| Automatic Classification of Cellular Expression by Nonlinear Stochastic Embedding (ACCENSE). | Q37475009 | ||
| The vasculature in rheumatoid arthritis: cause or consequence? | Q37534978 | ||
| Cytokines as biomarkers in rheumatoid arthritis | Q37661549 | ||
| B cells in the pathogenesis and treatment of rheumatoid arthritis | Q37678888 | ||
| ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial | Q37691090 | ||
| Autoantibodies to posttranslational modifications in rheumatoid arthritis | Q37693939 | ||
| Biomarkers for rheumatoid arthritis: making it personal | Q37761911 | ||
| Review of treatment response in rheumatoid arthritis: assessment of heterogeneity | Q37832733 | ||
| Abatacept mechanism of action: concordance with its clinical profile | Q37959086 | ||
| New biomarkers in rheumatoid arthritis | Q38057572 | ||
| Cytokine-producing B cells as regulators of pathogenic and protective immune responses | Q38068692 | ||
| Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis | Q39701973 | ||
| Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab | Q42911721 | ||
| Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis | Q44541019 | ||
| Antigen microarray profiling of autoantibodies in rheumatoid arthritis. | Q46107435 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| rheumatism | Q684924 | ||
| biomarker | Q864574 | ||
| biomedical investigative technique | Q66648976 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 127 | |
| P577 | publication date | 2015-05-18 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy | |
| P478 | volume | 17 |
| Q41936214 | A computational approach for phenotypic comparisons of cell populations in high-dimensional cytometry data. |
| Q28080053 | Biomarkers to guide clinical therapeutics in rheumatology? |
| Q92136028 | Candidate Markers for Stratification and Classification in Rheumatoid Arthritis |
| Q91949985 | Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2019 Conference Workshops |
| Q40099659 | Deep Immune Profiling of an Arginine-Enriched Nutritional Intervention in Patients Undergoing Surgery |
| Q38593065 | Emerging Proteomic Technologies Provide Enormous and Underutilized Potential for Brain Cancer Research. |
| Q41918189 | Guidelines for the use of flow cytometry and cell sorting in immunological studies |
| Q41761175 | High standards for high dimensional investigations. |
| Q92469045 | How Clinical Flow Cytometry Rebooted Sepsis Immunology |
| Q92357193 | Immune monitoring using mass cytometry and related high-dimensional imaging approaches |
| Q36519000 | Immunocapture strategies in translational proteomics. |
| Q36144937 | Informatics-Based Discovery of Disease-Associated Immune Profiles |
| Q41024183 | Mass Cytometry for Detection of Silver at the Bacterial Single Cell Level. |
| Q36900829 | Metabolic dysfunction and adipose tissue macrophages: is there more to glean from studying the lean?: Comment on "Adipose tissue infiltration in normal-weight subjects and its impact on metabolic function" by Moreno-Indias et al |
| Q61136608 | Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission |
| Q52850393 | OMIP-034: Comprehensive immune phenotyping of human peripheral leukocytes by mass cytometry for monitoring immunomodulatory therapies. |
| Q91245655 | Optimization of Receptor Occupancy Assays in Mass Cytometry: Standardization Across Channels with QSC Beads |
| Q50177437 | Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies |
| Q92898928 | Rigor and Reproducibility of Cytometry Practices for Immuno-Oncology: A multifaceted challenge |
| Q38836544 | Role of Immune Aging in Susceptibility to West Nile Virus. |
| Q53044556 | Silver nanoparticles for the detection of cell surface antigens in mass cytometry. |
| Q91780901 | Stabilizing Antibody Cocktails for Mass Cytometry |
| Q92527809 | Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials |
Search more.